Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome

Pediatric Pulmonology

Volumn 24, Issue 5, 1997, Pages 370-373

  Creery, W David ^a   Hashmi, Aijaz ^a   Hutchison, James S ^a   Singh, Ram N ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Acquired immunodeficiency syndrome; Acute respiratory distress syndrome; Human immunodeficiency virus; Infant; Pneumocystis carinii pneumonia; Surfactant

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CEFUROXIME; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; FLUCONAZOLE; LUNG SURFACTANT; METHYLPREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; ENDOTRACHEAL TUBE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; LYMPHOCYTE COUNT; MALE; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; BLOOD GAS ANALYSIS; CATTLE; FATAL OUTCOME; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMONIA, PNEUMOCYSTIS; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0030732111     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199711)24:5<370::AID-PPUL10>3.0.CO;2-6     Document Type: Article

References (12)

1. Goodwin SD. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children. Pharmacotherapy. 1993; 13:640-646.
2. Escamilla R, Prevost MC, Hermant C, Caratero A, Cariven C, Krempf M. Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients. Chest. 1992; 101:1558-1562.
3. Eijking EP, van Daal GJ, Tenbrinck R, Sluiters JF, Hannappel E, Erdmann W, Lachmann B. Improvement of pulmonary gas exchange after surfactant replacement in rats with Pneumocystis carinii pneumonia. Adv Exp Med Biol. 1992; 316:293-298.
4. Harms K, Herting E. Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia. Respiration. 1994; 61:348-352.
5. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis. 1993; 147:218-233.
6. Slater AJ, Nichani SH, Macrae D, Wilkinson KA, Novelli V, Tasker RC. Surfactant adjunctive therapy for Pneumocystis carinii pneumonitis in an infant with acute lymphoblastic leukaemia. Intens Care Med. 1995; 21:261-263.
7. Sleasman JW, Hemenway C, Klein AS, Barrett DJ. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. Am J Dis Child. 1993; 147:30-34.
8. Lewis JF, Dhillon J, Singh RN, Johnson CC, Frewen TC. Exogenous surfactant therapy for pediatric patients with acute respiratory distress syndrome. Can Respir J. 1997; 4:21-26.
9. Guillemi S, Belzberg A, Lawson LM. Adjunctive corticosteroid therapy decreases lung permeability in patients with AIDS-related Pneumocystis carinii pneumonia. Can Respir J. 1995; 2:55-57.
10. Gagnon S, Boota AM, Fischl MA. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome. N Engl J Med. 1990; 323:1444-1450.
11. Bozzette SA, Sattler FR, Chiu J. A Controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990; 323:1451-1456.
12. Oxtoby MJ. Vertical transmission of HIV in the United States. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children and Adolescents, 2nd ed. Baltimore: Williams & Wilkins, 1994:1-15.